Acurx Pharmaceuticals Llc Stock Price Prediction
| ACXP Stock | USD 2.74 0.01 0.36% |
Momentum 35
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.38) | EPS Estimate Current Year (5.71) | EPS Estimate Next Year (3.71) | Wall Street Target Price 61.7 | EPS Estimate Current Quarter (1.49) |
Using Acurx Pharmaceuticals hype-based prediction, you can estimate the value of Acurx Pharmaceuticals LLC from the perspective of Acurx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Acurx Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Acurx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Acurx Pharmaceuticals after-hype prediction price | USD 2.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Acurx Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acurx Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acurx Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Acurx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acurx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Acurx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Acurx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Acurx Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acurx Pharmaceuticals' historical news coverage. Acurx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.14 and 10.12, respectively. We have considered Acurx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Acurx Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Acurx Pharmaceuticals LLC is based on 3 months time horizon.
Acurx Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Acurx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acurx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acurx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.95 | 7.30 | 0.08 | 0.25 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.74 | 2.74 | 0.00 |
|
Acurx Pharmaceuticals Hype Timeline
Acurx Pharmaceuticals LLC is presently traded for 2.74. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of -0.25. Acurx is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.95%. %. The volatility of related hype on Acurx Pharmaceuticals is about 2734.08%, with the expected price after the next announcement by competition of 2.49. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acurx Pharmaceuticals LLC recorded a loss per share of 8.18. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 5th of August 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Acurx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Acurx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Acurx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Acurx Pharmaceuticals' future price movements. Getting to know how Acurx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acurx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APRE | Aprea Therapeutics | (0.02) | 10 per month | 0.00 | (0.25) | 4.40 | (8.11) | 17.87 | |
| ADIL | Adial Pharmaceuticals | (0.01) | 8 per month | 0.00 | (0.18) | 5.56 | (6.25) | 16.67 | |
| BCDA | Biocardia | (0.06) | 8 per month | 0.00 | (0.05) | 5.93 | (5.76) | 21.46 | |
| HCWB | HCW Biologics | (0.50) | 8 per month | 0.00 | (0.22) | 13.02 | (11.97) | 41.72 | |
| GLTO | Galecto | (0.40) | 11 per month | 7.31 | 0.12 | 17.97 | (14.66) | 273.14 | |
| CELZ | Creative Medical Technology | (0.16) | 10 per month | 0.00 | (0.09) | 9.31 | (11.22) | 50.90 | |
| KPRX | Kiora Pharmaceuticals | (0.04) | 6 per month | 0.00 | (0.07) | 5.32 | (6.25) | 21.80 | |
| INAB | In8bio Inc | (0.03) | 8 per month | 4.93 | 0.03 | 14.29 | (9.18) | 37.96 | |
| APVO | Aptevo Therapeutics | (1.44) | 6 per month | 0.00 | (0.25) | 7.81 | (9.42) | 45.42 | |
| BCLI | Brainstorm Cell Therapeutics | (0.01) | 6 per month | 0.00 | (0.02) | 9.09 | (6.67) | 24.01 |
Acurx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Acurx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acurx using various technical indicators. When you analyze Acurx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Acurx Pharmaceuticals Predictive Indicators
The successful prediction of Acurx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Acurx Pharmaceuticals LLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Acurx Pharmaceuticals based on analysis of Acurx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Acurx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Acurx Pharmaceuticals's related companies. | 2023 | 2025 | 2026 (projected) | Current Ratio | 2.53 | 1.37 | 1.3 | Net Debt To EBITDA | 0.51 | 0.59 | 0.84 |
Pair Trading with Acurx Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acurx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Acurx Stock
| 0.9 | DRMA | Dermata Therapeutics Trending | PairCorr |
| 0.8 | VINC | Vincerx Pharma Common | PairCorr |
| 0.81 | VYGR | Voyager Therapeutics | PairCorr |
| 0.8 | SLN | Silence Therapeutics PLC | PairCorr |
Moving against Acurx Stock
| 0.77 | HLN | Haleon plc Aggressive Push | PairCorr |
| 0.73 | MARUF | Marubeni | PairCorr |
| 0.71 | CAPR | Capricor Therapeutics | PairCorr |
| 0.7 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.7 | CNOB | ConnectOne Bancorp Earnings Call This Week | PairCorr |
| 0.61 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Acurx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acurx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acurx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acurx Pharmaceuticals LLC to buy it.
The correlation of Acurx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acurx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acurx Pharmaceuticals LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acurx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.